ProSomnus, Inc. (OSA) Research

ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA). This enterprise, which originated in 2016, maintains its headquarters in Pleasanton, California.

Market snapshot

Symbol
OSA
Price
$0.47
Day change
0.00%
Market cap
$8.2M
P/E ratio
-0.32x
52-week range
0.47-0.5
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Biora Therapeutics, Inc. (BIOR)
  • Centogene N.V. (CNTG)
  • COSCIENS Biopharma Inc. (CSCI)
  • Neoleukin Therapeutics, Inc. (NLTX)
  • NeuroMetrix, Inc. (NURO)
  • Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)
  • Omega Therapeutics, Inc. (OMGA)
  • SunLink Health Systems, Inc. (SSY)

Recent insider activity

  • Kim Sung — A-Award (315742 shares) on 2024-02-15
  • Dow Brian B — A-Award (315742 shares) on 2024-02-15
  • Liptak Len — A-Award (1322756 shares) on 2024-02-15
  • Rikkers Laing — trade (0 shares) on 2022-12-06
  • Rikkers Laing — trade (0 shares) on 2022-12-06

Open ProSomnus, Inc. (OSA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.